EUVIMED · CrossrefZeitschrift
Pharmacogenetics and Genomics
ISSN 1744-6872 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Bayesian Additive Regression Trees modeling of pharmacogenomic and clinical data predicts amlodipine response in hypertension
Prevalence of CYP2C19 phenotypes in patients undergoing a hiatal hernia repair
The HTR2A rs6311 and rs6313 polymorphisms and atypical antipsychotics response in schizophrenia: a scoping review
Vitamin D receptor regulate placental ABCB1 expression transcriptionally by recruiting coactivator SRC-1
Low expression of ZFP36L2 causes glucocorticoid resistance in childhood T-cell acute lymphoblastic leukemia
Knowledge and perspectives on pharmacogenomic-guided antidepressant treatment among psychiatrists and primary care practitioners
The role of pro-inflammatory cytokine gene polymorphisms in major depressive disorder: a systematic review
Evaluating the impact of SDHAF3 p.F53L genetic variant on clinically significant QTc prolongation in patients prescribed high-risk medications: a retrospective pharmacogenetic study
Application of risk priority number of failure mode and effects analysis to drug–variant pairs for severe cutaneous adverse reactions in Korean and American populations
The potential effect and pathway of valsartan: genome-wide and phenome-wide association study from UK Biobank data
Effects of apolipoprotein E and solute carrier organic anion transporter family member 1B1 gene polymorphisms on statin efficacy and safety in dyslipidemic patients
CFTR genotype–phenotype associations and clinical outcomes in pediatric cystic fibrosis
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease
Characteristics of initial pharmacogenetic testing and subsequent physician referral behavior in youth mental health
Pharmacogenomics clinical decision support for patients who have undergone liver transplant or allogenic stem cell transplant
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: Erratum
Pharmacogenomics of commonly used intravenous anesthetics
Pharmacogenomics-guided personalized medicine in a clinical setting: real-world data
Pharmacogenetic testing coverage by Canadian insurance providers
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation
Polygenic risk score for drug-induced long QT syndrome: independent validation in a real-world patient cohort
Comparative performance of pharmacogenetics-based warfarin dosing algorithms in Chinese population: use of a pharmacokinetic/pharmacodynamic model to explore dosing regimen through clinical trial simulation
Impact of UGT1A4 and UGT2B7 polymorphisms on lamotrigine plasma concentration in patients with bipolar disorder
Pan-cancer single-cell landscape of drug-metabolizing enzyme genes
Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens–Johnson syndrome/toxic epidermal necrolysis
PharmGKB summary: disulfiram pathway
Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants
N-acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer
Implementation of pharmacogenomics into inpatient general medicine
Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects
EUVIMED